Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...
Lomond Therapeutics, Inc., a clinical-stage biotechnology company dedicated to discovering and developing potentially best-in-class and first-in-class medicines for the treatment of hematological ...
BCL Industries shares saw an uptick after the company announced a 17 percent higher allocation quota for supplying ethanol to Oil Marketing Companies (OMCs) in the current fiscal year. The ...
A study published Oct. 2 in Nature is the first to explain the pathway of TET2's enzymatic activity that is essential for its tumor-suppressing function. Mingjiang Xu, PhD, a molecular medicine ...
Two symposia occurred during the European Respiratory Society (ERS) Congress 2024, highlighting the heterogeneity in chronic inflammatory pathways that underlie chronic obstructive pulmonary disease ...
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, and Sichuan Research Center for Drug Precision Industrial Technology, West China School of ...
In fact, Wilkinson hopes an agreement between the Pathways Alliance consortium, Ottawa and Alberta can soon be reached to get one of the world’s largest carbon capture networks moving ...
“Therefore, I think it is important for us to then think … how do we create a lot more choices, a lot more flexible pathways to cater to the needs of the different students and also to meet ...